These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Silicone granuloma of the face treated with minocycline. Arin MJ; Bäte J; Krieg T; Hunzelmann N J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):53-6. PubMed ID: 15692516 [TBL] [Abstract][Full Text] [Related]
5. Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept. Zeichner JA; Stern DW; Lebwohl M J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S120-1. PubMed ID: 16488322 [No Abstract] [Full Text] [Related]
6. Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. Lin JH; Liebhaber M; Roberts RL; Dyer Z; Stiehm ER J Allergy Clin Immunol; 2006 Apr; 117(4):878-82. PubMed ID: 16630948 [TBL] [Abstract][Full Text] [Related]
9. Etanercept is minimally effective in 2 children with atopic dermatitis. Buka RL; Resh B; Roberts B; Cunningham BB; Friedlander S J Am Acad Dermatol; 2005 Aug; 53(2):358-9. PubMed ID: 16021144 [No Abstract] [Full Text] [Related]
10. Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept. Litton G Am J Hematol; 2008 Apr; 83(4):344. PubMed ID: 18186526 [No Abstract] [Full Text] [Related]
11. A case of mucocutaneous Behçet's disease responding to etanercept. Sommer A; Altmeyer P; Kreuter A J Am Acad Dermatol; 2005 Apr; 52(4):717-9. PubMed ID: 15793540 [No Abstract] [Full Text] [Related]
12. Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept. Prey S; Robert PY; Drouet M; Sparsa A; Roux C; Bonnetblanc JM; Bédane C Acta Derm Venereol; 2007; 87(1):74-5. PubMed ID: 17225020 [No Abstract] [Full Text] [Related]
14. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept. Yamauchi PS; Lowe NJ; Gindi V J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S121-2. PubMed ID: 16488323 [No Abstract] [Full Text] [Related]
15. Successful use of infliximab following a failed course of etanercept in a pediatric patient. Farnsworth NN; George SJ; Hsu S Dermatol Online J; 2005 Dec; 11(3):11. PubMed ID: 16409907 [No Abstract] [Full Text] [Related]
16. Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis. Yamauchi PS; Lowe NJ J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S135-8. PubMed ID: 16488328 [No Abstract] [Full Text] [Related]
17. Etanercept for the treatment of severe childhood psoriasis. Papoutsaki M; Costanzo A; Mazzotta A; Gramiccia T; Soda R; Chimenti S Br J Dermatol; 2006 Jan; 154(1):181-3. PubMed ID: 16403117 [No Abstract] [Full Text] [Related]
18. Etanercept for chronic progressive cutaneous sarcoidosis. Tuchinda C; Wong HK J Drugs Dermatol; 2006 Jun; 5(6):538-40. PubMed ID: 16774106 [TBL] [Abstract][Full Text] [Related]
19. Ability to develop rhus allergic contact dermatitis in a patient with psoriasis receiving etanercept. Myers W; Newman M; Katz B; Gottlieb AB J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S127-8. PubMed ID: 17052536 [No Abstract] [Full Text] [Related]
20. Effect of etanercept on matrix metalloproteinases and angiogenic vascular endothelial growth factor: a time kinetic study. Aggarwal A; Panda S; Misra R Ann Rheum Dis; 2004 Jul; 63(7):891-2. PubMed ID: 15194595 [No Abstract] [Full Text] [Related] [Next] [New Search]